2.4K Views
•
09:40 min
•
August 2nd, 2024
DOI :
August 2nd, 2024
•Transcript
Explore More Videos
Chapters in this video
0:00
Introduction
0:51
Analyzing the Expression of TMOD3 in Normal Ovarian Tissues and Ovarian Cancer
2:23
Assessing the Effect of TMOD3 on Overall Survival and Progression‐Free Survival (PFS) in Ovarian Cancer Patients
4:15
TMOD3 Expression Analysis in Platinum‐Based Chemotherapy Resistant and Sensitive Patients and mRNA‐miRNA Analysis
6:56
Checking the Distribution of TMOD3 in Immune Cells and TMOD3 Coexpression Networks in Ovarian Cancer
Related Videos
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
9.5K Views
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
8.8K Views
Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis
5.7K Views
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
6.6K Views
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
4.7K Views
Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
4.0K Views
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
1.5K Views
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
1.3K Views
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
918 Views
Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
497 Views
Copyright © 2025 MyJoVE Corporation. All rights reserved